The long-term effects of low-dose 17β-estradiol and dydrogesterone hormone replacement therapy on 24-h ambulatory blood pressure in hypertensive postmenopausal women: a 1-year randomized, prospective study

Author： Kaya C.   Cengiz S. Dincer   Cengiz B.   Akgun G.  

Publisher： Informa Healthcare

ISSN： 1473-0804

Source： Climacteric, Vol.9, Iss.6, 2006-12, pp. : 437-445

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

1 and 2 mg 17β-estradiol combined with sequential dydrogesterone have similar effects on the serum lipid profile of postmenopausal women

By Stevenson J. C.   Rioux J. E.   Komer L.   Gelfand M.  

Climacteric, Vol. 8, Iss. 4, 2005-12 ,pp. : 352-359

Informa Healthcare

Access to resources Recommend Favorite

Low-dose oral combination of 17β-estradiol and norethisterone acetate in postmenopausal women decreases factor VII, fibrinogen, antithrombin and plasminogen activator inhibitor-1

By Borgfeldt C.   Li C.   Samsioe G.  

Climacteric, Vol. 7, Iss. 1, 2004-01 ,pp. : 78-85

Informa Healthcare

Access to resources Recommend Favorite

Hormone replacement therapy in postmenopausal women with Alzheimer's disease: a randomized, prospective study

By Yoon B.-K.   Kim D.K.   Kang Y.   Kim J.-W.   Shin M.-H.   Na D.L.  

Fertility and Sterility, Vol. 79, Iss. 2, 2003-02 ,pp. : 274-280

Elsevier

Access to resources Recommend Favorite

Is low-dose hormone replacement therapy for postmenopausal women efficacious and desirable?

By Lobo R. A.   Whitehead M. I.  

Climacteric, Vol. 4, Iss. 2, 2001-06 ,pp. : 110-119

Informa Healthcare

Access to resources Recommend Favorite

One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women

By Genazzani A. R.  

Climacteric, Vol. 16, Iss. 4, 2013-08 ,pp. : 490-498

Informa Healthcare

Access to resources Recommend Favorite